CAS 2168561-20-2

Nurulimab

CAS : 2168561-20-2

Nurulimab (BCD-145) is an anti-CTLA-4 antibody with anti-cancer activity for the study of skin and musculoskeletal diseases.

Degré de pureté : 95.5% (SDS-PAGE); 97.3% (SEC-HPLC) - 95.5% (SDS-PAGE); 97.3% (SEC-HPLC)

Couleur et forme : Liquid

Ref: TM-T77103

Nurulimab

CAS : 2168561-20-2

Monoclonal antibody targeting cytotoxic T-lymphocyte-associated antigen 4 (CTLA4); elimination of cancer cells

Ref: 3D-CLA1599